메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules.1 Enables accurate analysis of protein complexes, nucleic acids, and gene delivery vehicles, including distinguishing between empty, partial, full, and overfull viral vector capsids in less than 10 minutes per sample.2 Decreases sample volumes by 100 times vs. current methods for assessing cells and nucleic acids.3 MILFORD, Mass., Oct. 13, 2025 -- Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS)
- 김갑성 기자
- 2025-10-13 20:36
Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration

SHANGHAI, Oct. 13, 2025 -- Thousand Oaks Biologics' antibody-drug conjugate (ADC) manufacturing site successfully passed an audit conducted by a European Union Qualified Person (QP) and formally received a QP Declaration. This milestone certifies that the company's quality management system and commercial production capability in the field of antibody-drug conjugates (ADCs) comply with EU Good Manufacturing Practice (GMP) standards, positioning Thousand Oaks Biologics Shanghai as one of the few CDMOs in China offering end-to-end international ADC services. The five-day on-site audit to
- 김갑성 기자
- 2025-10-13 20:00
Chiron Medical Launches "Early Check, Early Hope" Campaign, Embracing Pink for Breast Cancer Awareness

HONG KONG, Oct. 13, 2025 -- According to government statistics[1], breast cancer ranks as the third leading cause of cancer deaths among women in Hong Kong, with an average of one in every 14 women likely to be diagnosed with the disease in their lifetime. The medical community widely believes that early detection significantly increases the success rate of treatment, making regular screenings and disease awareness essential. In celebration of Pink Day and International Breast Cancer Awareness Month, Chiron Medical invites all sectors to participate in launching "Early Check, Early Hope,
- 김갑성 기자
- 2025-10-13 19:46
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

ANDERNACH, Germany, Oct. 13, 2025 -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC ("Renaissance"), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. With the acquisition, Renaissance facilities will become part of the worldwide operations network of LTS, along with LTS' existing facilities in Andernach, Germany, West Caldwell, NJ, US, St. Paul, MN, US and Netanya, Israel. The acquisitio
- 김갑성 기자
- 2025-10-13 18:00
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease

BRISBANE, Calif. , Oct. 13, 2025 -- ReviR Therapeutics, a biotech company focused on developing novel treatments for neurogenetic diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for RTX-117, its lead investigational therapy for Charcot-Marie-Tooth disease (CMT). ReviR is preparing to launch a Phase 1 clinical trial in healthy volunteers in early 2026 to evaluate the safety, tolerability, and pharmacokinetics of RTX-117, with a Phase Ib/IIa study in CMT patients planned to follow. CMT is the most prevalent inherited p
- 김갑성 기자
- 2025-10-13 18:00
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025

TAIPEI, Oct. 13, 2025 -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's disease) was selected as one of the seven Late-Breaking Abstracts at the World Muscle Society (WMS) 2025 International Congress in Vienna. Dr. Tahseen Mozaffar, an investigator of the study, presented the study outcome, emphasizing the therapeutic potential of AJ201 for SBMA patients. AJ201, an oral suspension of a novel curcumin analog-Rosolutamide, offers ease of use for patients with s
- 김갑성 기자
- 2025-10-13 16:03
Zhang Xinyuan, a Chinese gender relationship expert, leads thousands of women to challenge the Guinness World Records

BOAO, China, Oct. 13, 2025 -- In 2025, the Boao Forum for Asia International Conference Center in Hainan, China, hosted a highly anticipated international health event. Zhang Xinyuan,the founder and chairman of Vimi Wellness (Hangzhou) Co., Ltd. and a renowned gender relationship expert, led thousands of women from various regions in China to successfully challenge the Guinness World Record for the "largest number of women performing pelvic floor muscle exercises." This event not only demonstrated the increasing attention Chinese women are paying to their own health management but a
- 노기식 기자
- 2025-10-13 15:00
The 138th Canton Fair is Set to Open in Guangzhou on October 15

GUANGZHOU, China, Oct. 13, 2025 -- The 138th China Import and Export Fair (Canton Fair) is set to open in Guangzhou from October 15 to November 4, divided into three phases. The fair will maintain its 24-hour online presence to offer global buyers continuous access to Chinese suppliers. With an exhibition area of 1.55 million square meters, this session will feature a record 74,600 booths and more than 32,000 participating enterprises. The 138th Canton Fair marks a new milestone in both scale and innovation. For the first time, more than 10,000 exhibitors hold titles such as &q
- 김갑성 기자
- 2025-10-13 14:42
Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies

[ 메디채널 김갑성 기자 ] Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism designed to reduce drug-resistant seizures in children and adults living with Developmental Epileptic Encephalopathies (DEEs) and improve quality of life for patients and their caregivers1 Dual Breakthrough Therapy Designation (BTD) in China and the U.S. underscores Lundbeck's mission to advance brain health and transform lives of patients with rare neurological diseases VALBY, Denmark, Oct. 13, 2025 -- Lundbeck tod
- 김갑성 기자
- 2025-10-13 14:26
ISTH marks World Thrombosis Day with urgent global call to action

[ 메디채널 김갑성 기자 ] Thrombosis is the underlying cause of 1 in 4 deaths worldwide each year. The campaign calls for crucial awareness and prevention. CHARLOTTE, N.C., Oct. 13, 2025 -- The International Society on Thrombosis and Haemostasis (ISTH) today marks World Thrombosis Day, a global movement uniting thousands of partners in more than 120 countries. This year's campaign, "From Head to Toe, Take Control. Prevent Thrombosis. Protect Your Health," calls for greater awareness of thrombosis and action to reduce its burden worldwide. Observed annually on October
- 김갑성 기자
- 2025-10-13 14:00

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-11-04_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 01시 20분